SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The Amateur Traders Corner
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rogermci® who wrote (17723)12/31/2001 8:06:57 AM
From: Tom Hua  Read Replies (2) of 19633
 
Good morning Roger, IMCL down 10 pts at this time. I started a SS at 45.9.

07:50 ET Imclone Sys (IMCL) 55.25: -- Update -- UBS Warburg believes that
the FDA request for more information on Erbitux will push back approval of the
drug by at least 6 months. As a result, firm is pushing out its revenue stream for the
drug to 2003 from 2002 and reducing price target to $62. In rejecting the filing, the
FDA sited deficiencies in documentation of inclusion criteria and determination of
response. IMCL will hold a conference call at 8:30 to discuss the FDA decision:
888-849-9221.

Regards,

Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News